Fortrea (NASDAQ:FTRE) Hits New 1-Year High on Strong Earnings

Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) hit a new 52-week high during mid-day trading on Wednesday following a better than expected earnings announcement. The company traded as high as $21.12 and last traded at $20.70, with a volume of 3237937 shares trading hands. The stock had previously closed at $19.20.

The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. Fortrea had a negative net margin of 3.18% and a positive return on equity of 10.72%. The business had revenue of $678.20 million during the quarter, compared to analysts’ expectations of $647.57 million.

Fortrea News Roundup

Here are the key news stories impacting Fortrea this week:

• Positive Sentiment: Fortrea reported second-quarter adjusted earnings of $0.23 per share, exceeding the $0.18 analyst consensus, while revenue of $678.2 million topped expectations of $647.6 million. Earnings also increased from $0.19 per share a year earlier. Fortrea Q2 Earnings Beat
• Positive Sentiment: The company raised or increased its full-year outlook, forecasting 2026 revenue of approximately $2.62 billion to $2.69 billion. Management highlighted four consecutive quarters of improved commercial, operational and financial execution, supporting the bullish case. Fortrea Reports Second Quarter 2026 Results
• Positive Sentiment: Truist Financial raised its price target on Fortrea from $19 to $26 and upgraded the stock to “Buy,” implying substantial potential upside from recent trading levels. The change reflects increased confidence following the earnings results and guidance. Truist Raises Fortrea Price Target
• Neutral Sentiment: Fortrea’s positive quarterly performance was accompanied by a negative net margin, indicating that profitability remains uneven despite the adjusted earnings beat. Analysts currently expect approximately $0.80 in earnings per share for the full fiscal year. Fortrea Earnings Report
• Negative Sentiment: The board appointed director David Smith as interim chief financial officer amid an ongoing legal dispute involving former CFO Michael Madlock and a related covenant proceeding. The management transition and legal uncertainty could weigh on investor confidence and partially offset the strong operating results. Fortrea Names Interim CFO

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. Citigroup lifted their target price on shares of Fortrea from $16.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Barclays raised their price target on Fortrea from $18.00 to $22.00 and gave the company an “equal weight” rating in a report on Thursday. Evercore reiterated an “outperform” rating on shares of Fortrea in a research report on Wednesday. Mizuho boosted their price objective on Fortrea from $13.00 to $16.00 and gave the stock a “neutral” rating in a research note on Monday, July 13th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Fortrea in a report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Fortrea has an average rating of “Moderate Buy” and an average price target of $19.75.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in FTRE. Larson Financial Group LLC grew its position in shares of Fortrea by 136.7% during the 4th quarter. Larson Financial Group LLC now owns 1,856 shares of the company’s stock worth $32,000 after buying an additional 1,072 shares during the period. Osaic Holdings Inc. lifted its holdings in Fortrea by 74.3% in the second quarter. Osaic Holdings Inc. now owns 6,844 shares of the company’s stock valued at $38,000 after buying an additional 2,918 shares during the period. Tower Research Capital LLC TRC lifted its holdings in Fortrea by 137.0% in the second quarter. Tower Research Capital LLC TRC now owns 8,713 shares of the company’s stock valued at $43,000 after buying an additional 5,036 shares during the period. Toronto Dominion Bank bought a new position in Fortrea in the fourth quarter valued at approximately $51,000. Finally, EverSource Wealth Advisors LLC boosted its stake in Fortrea by 662.9% in the second quarter. EverSource Wealth Advisors LLC now owns 11,963 shares of the company’s stock valued at $59,000 after acquiring an additional 10,395 shares during the last quarter.

Fortrea Stock Down 6.5%

The business’s fifty day simple moving average is $16.93 and its 200 day simple moving average is $13.80. The company has a current ratio of 0.96, a quick ratio of 0.95 and a debt-to-equity ratio of 1.98. The stock has a market cap of $1.80 billion, a price-to-earnings ratio of -20.97, a price-to-earnings-growth ratio of 0.62 and a beta of 2.03.

Fortrea Company Profile

Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific’s Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company’s comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.

Fortrea’s core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.